Back to Search
JEFFREY HERMAN, DO
DO
Internal Medicine Physician
NPI: 1992807358IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
JH009628(MI)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Class of 1986
Research & Publications (20)
Radiotherapy using a water bath in the treatment of Bowen's disease of the digit.
PMID 18571754·Radiother Oncol·2008
8-other
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
PMID 18640931·J Clin Oncol·2008
8-other
Gas-phase reactivity of selected transition metal cations with CO and CO2 and the formation of metal dications using a sputter ion source.
PMID 17388338·J Phys Chem A·2007
8-other
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
PMID 15245938·Urology·2004
3-trial
Gene silencing in cancer in association with promoter hypermethylation.
PMID 14627790·N Engl J Med·2003
6-review
Hypermethylation pathways to colorectal cancer. Implications for prevention and detection.
PMID 12489271·Gastroenterol Clin North Am·2002
6-review
Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.
PMID 12075125·Toxicol Sci·2002
7-preclinical
Incidence and risk factors for the development of indinavir-associated renal complications.
PMID 11532999·J Antimicrob Chemother·2001
8-other
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
PMID 19647950·Int J Radiat Oncol Biol Phys·2010
8-other
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.
PMID 19394156·Int J Radiat Oncol Biol Phys·2010
4-observational
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
PMID 19509152·Clin Cancer Res·2009
8-other
Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
PMID 19644351·Ann Surg·2009
4-observational
Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.
PMID 19541379·Radiother Oncol·2009
4-observational
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
PMID 19535783·J Natl Cancer Inst·2009
8-other
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
PMID 19546476·Blood·2009
3-trial
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
PMID 19584151·Clin Cancer Res·2009
8-other
DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.
PMID 19584833·Am J Gastroenterol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1435 N MILFORD RD, STE 101
MILFORD, MI 48381 - Phone
- (248) 685-9780
Quick Facts
- NPI
- 1992807358
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile